The COVID-19 immunization at first started on sixteenth January in India to just frontline medical services officers. Since this was an extreme pandemic, various examinations would have various perspectives. The specialists overall say those patients with comorbidities are at a higher danger of getting influenced by serious COVID-19 disease. Visit our site to know more about myths and facts about that people with comorbidities get a COVID-19 vaccine.
#COVID-19vaccine
#mythsandfactsaboutCOVID-19vaccine
US federal health officials said vaccinated Americans will need to get booster shots 8 months after receiving their 2nd dose of a Covid-19 vaccine.
It would maximize its protection against the virus and enhance its durability Read more...
It has always been evident that India is using its strength to secure COVID-19 vaccine in many ways since the beginning of this conflict.
It is also made clear that frontline workers and vulnerable section will get the dose in priority.
Worldwide Flight Services (WFS) has launched Project Coldstream to co-ordinate its response to the anticipated global transportation of some 16 billion doses of Covid-19 vaccine, expected to commence in late 2020 and continue through 2021/2022.
We conduct an accurate and reliable COVID Test.
Our qualified phlebotomists trained for safe and hygienic sample collecting during Test for COVID 19.
We are the most trustworthy lab for COVID 19 testing in India.
Get your COVID-19 Test done with Metropolis Healthcare.
On Aug, 15, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices is scheduled to meet Friday to discuss further clinical recommendations regarding immunocompromised individuals.
Today’s action does not apply to people who are not immunocompromised.
“The country has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease.
After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna Vaccines,” said Acting FDA Commissioner Janet Woodcock, M.D.
As we’ve previously stated, other individuals who are fully vaccinated are adequately protected and do not need an additional dose of COVID-19 vaccine at this time.